Cyclosporine in patient-specific dose strengths
Specialized Clinical Programs · Cyclosporine for Transplant
Compounded Cyclosporine for Transplant Patients
Voshell’s compounds patient-specific cyclosporine and related specialty immunosuppressants — supporting transplant programs at Baltimore-area medical centers and across the East Coast.
Transplant patients require immunosuppressant precision that off-the-shelf formulations cannot always provide. Allergen sensitivities, dose adjustments outside commercially available strengths, alternative delivery routes for patients who cannot tolerate standard preparations — these are the specialty compounding needs transplant care teams bring to a 503A partner. Voshell’s compounds cyclosporine and related specialty immunosuppressants under sterile, patient-specific specifications developed in partnership with attending transplant clinicians.
What Voshell’s Compounds for Transplant Care Teams
Alternative delivery routes when standard oral preparations are not tolerated
Allergen-free reformulations when commercial preparations contain sensitivities
Pediatric dose-precision for transplant patients in pediatric specialty care
Related specialty immunosuppressants under patient-specific prescriber specifications
Compliance
How Hospital and Transplant Program Partnership Works
Voshell’s transplant compounding is delivered through hospital pharmacy partnerships and direct prescriber relationships. Programs typically begin with a discovery conversation between the Voshell’s pharmacist team and the hospital pharmacy director or transplant program clinical lead.
Compliance Note
Cyclosporine and related immunosuppressants are compounded only under valid prescription from a licensed prescriber. Compounded medications are not FDA-approved as finished drug products; their use should be guided by a licensed healthcare provider familiar with the patient’s medical history. Information on this page is for educational purposes only.